News - 12 Apr 2013
Government officials, academic, and industry leaders gathered to celebrate the official opening of the Single-Cell Omics Centre (SCOC) in Singapore today.
It is the first research centre in Asia...
News - 6 Apr 2010
Rosetta Genomics, Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announced today that starting April 1, 2010 physicians are able to send FNA cell block...
News - 19 May 2010
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, announces the publication of a study entitled, “Discovery of microRNAs and...
Article - 4 Aug 2006
CPI has identified six key drivers influencing the transformation of the healthcare sector, which will create many opportunities for innovation.
Article - 29 Aug 2005
There is a fear that the chaotic situation regarding nanotechnology patenting could hamper the development of nanotechnologies. An overview of what has been happening in the area of nano-patenting...
Article - 8 Apr 2005
Worldwide public funding of nanotechnology research projects has seen significant increases over the last few years. Japan and the USA lead the way in public funding, the setting up of research...
News - 2 Oct 2008
WaferGen Biosystems, Inc., a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced that Alnoor Shivji, WaferGen's...
Article - 11 May 2004
BioTrove, Inc., a biotechnology company developing and commercializing nano-fluidic systems for the life sciences, today announced the appointment of Michael Olex as Vice President, Manufacturing....
News - 20 Apr 2013
A partnership between the University of Birmingham, BGI and its open-access journal, GigaScience, has received funding from the UK's Natural Environment Research Council (NERC) to develop a...
News - 9 Mar 2009
A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity, according to Harvey Pass, M.D. of the NYU Cancer...